JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Pfizer
PFE
|
+$919M |
| 3 |
Microsoft
MSFT
|
+$718M |
| 4 |
Wells Fargo
WFC
|
+$679M |
| 5 |
PepsiCo
PEP
|
+$641M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$1.62B |
| 2 |
Johnson & Johnson
JNJ
|
+$1.19B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$754M |
| 4 |
Booking.com
BKNG
|
+$726M |
| 5 |
SLB Ltd
SLB
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.42% |
| 2 | Financials | 13.44% |
| 3 | Healthcare | 11.49% |
| 4 | Technology | 10.73% |
| 5 | Consumer Discretionary | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2176
ACI Worldwide
ACIW
$5.02B
| $5.37M | ﹤0.01% |
248,027
+109,027
| +78% | +$2.17M |
2013 Q2
7 quarters
|
|
|
FENG
2177
Phoenix New Media
FENG
$16.8M
| $5.37M | ﹤0.01% |
157,939
+41,063
| +35% | +$1.79M |
2014 Q2
3 quarters
|
|
|
PDLI
2178
DELISTED
PDL BioPharma, Inc.
PDLI
| $5.35M | ﹤0.01% |
760,773
-490,586
| -39% | -$3.55M |
2013 Q2
7 quarters
|
|
2179
Fidelity National Financial
FNF
$10.5B
| $5.35M | ﹤0.01% |
209,666
-7,379
| -3% | -$186K |
2013 Q2
7 quarters
|
|
|
MNTA
2180
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $5.34M | ﹤0.01% |
+351,425
| New | +$4.57M |
2015 Q1
0 quarters
|
|
|
INXN
2181
DELISTED
Interxion Holding N.V.
INXN
| $5.33M | ﹤0.01% |
188,928
+117,459
| +164% | +$3.44M |
2014 Q2
3 quarters
|
|
2182
Pan American Silver
PAAS
$18.6B
| $5.33M | ﹤0.01% |
607,395
+297,891
| +96% | +$3.06M |
2014 Q1
4 quarters
|
|
|
CJES
2183
DELISTED
C&J ENERGY SVCS LTD
CJES
| $5.32M | ﹤0.01% |
478,170
-625,750
| -57% | -$7.48M |
2013 Q2
7 quarters
|
|
2184
First Trust Consumer Staples AlphaDEX Fund
FXG
$201M
| $5.32M | ﹤0.01% |
119,111
+23,541
| +25% | +$1.04M |
2013 Q2
7 quarters
|
|
2185
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
| $5.31M | ﹤0.01% |
40,297
+50
| +0.1% | +$6.47K |
2014 Q4
1 quarter
|
|
2186
Invesco BuyBack Achievers ETF
PKW
$1.69B
| $5.31M | ﹤0.01% |
107,639
-19
| -0% | -$923 |
2013 Q2
7 quarters
|
|
2187
Quaker Houghton
KWR
$2.73B
| $5.31M | ﹤0.01% |
61,967
+32,838
| +113% | +$2.75M |
2013 Q2
7 quarters
|
|
2188
John B. Sanfilippo & Son
JBSS
$779M
| $5.3M | ﹤0.01% |
122,932
+56,207
| +84% | +$2.18M |
2013 Q2
7 quarters
|
|
2189
SLM Corp
SLM
$4.25B
| $5.28M | ﹤0.01% |
569,162
-138,856
| -20% | -$1.3M |
2013 Q2
7 quarters
|
|
2190
Fresenius Medical Care
FMS
$11.8B
| $5.28M | ﹤0.01% |
127,279
+78
| +0.1% | +$3.01K |
2013 Q2
7 quarters
|
|
|
GHDX
2191
DELISTED
Genomic Health, Inc.
GHDX
| $5.27M | ﹤0.01% |
172,591
+52,316
| +43% | +$1.66M |
2014 Q4
1 quarter
|
|
|
MSCC
2192
DELISTED
Microsemi Corp
MSCC
| $5.26M | ﹤0.01% |
148,554
+21,640
| +17% | +$669K |
2013 Q2
7 quarters
|
|
2193
Ultrapar
UGP
$7.82B
| $5.26M | ﹤0.01% |
520,716
+267,116
| +105% | +$2.61M |
2013 Q2
7 quarters
|
|
|
CRC
2194
DELISTED
California Resources Corporation
CRC
| $5.26M | ﹤0.01% |
69,078
-688,590
| -91% | -$42.1M |
2014 Q4
1 quarter
|
|
2195
Cabot Corp
CBT
$3.94B
| $5.25M | ﹤0.01% |
116,738
-336,446
| -74% | -$14.9M |
2013 Q2
7 quarters
|
|
|
TESO
2196
DELISTED
Tesco Corp
TESO
| $5.23M | ﹤0.01% |
459,937
-21,888
| -5% | -$240K |
2013 Q2
7 quarters
|
|
|
CSGS
2197
DELISTED
CSG Systems International
CSGS
| $5.22M | ﹤0.01% |
171,893
-226,478
| -57% | -$6.36M |
2013 Q2
7 quarters
|
|
2198
The Greenbrier Companies
GBX
$1.24B
| $5.2M | ﹤0.01% |
89,719
-269,841
| -75% | -$14.9M |
2014 Q3
2 quarters
|
|
|
JRO
2199
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $5.2M | ﹤0.01% |
447,000
| – | – |
2013 Q2
7 quarters
|
|
2200
PUT
Jazz Pharmaceuticals
JAZZ
$15.1B
| $5.18M | ﹤0.01% |
+30,000
| New | +$5.15M |
2015 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2015 Portfolio in Review
As of Q1 2015, JP Morgan Chase held 4,553 positions worth $439B, up 0.39% from $437B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2015 filing shows 344 new, 1,711 increased, 1,692 reduced and 516 closed positions. Its largest new stake was Xtrackers MSCI EAFE Hedged Equity ETF: 6,839,286 shares worth $205M. The largest sale was iShares MSCI EAFE ETF, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q1 2015 buy was Xtrackers MSCI EAFE Hedged Equity ETF: 6,839,286 shares worth $205M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2015 reduction was iShares MSCI EAFE ETF, cutting an estimated $1.62B.
- JP Morgan Chase fully exited CAREFUSION CORPORATION in Q1 2015, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 16% of its $439B portfolio in Q1 2015.
- JP Morgan Chase opened 344 new positions and closed 516 in Q1 2015.
- JP Morgan Chase's portfolio value rose 0.39% quarter-over-quarter to $439B.
Based on JP Morgan Chase's 13F filing for Q1 2015, filed 15 May 2015.